2014 Report on the International (Dry eye, Anti-glaucoma, Anti-allergy/inflammatory/infective, Retinal Drugs) Ophthalmic Drugs Market - Forecast to 2018 - WECT TV6-WECT.com:News, weather & sports Wilmington, NC

2014 Report on the International (Dry eye, Anti-glaucoma, Anti-allergy/inflammatory/infective, Retinal Drugs) Ophthalmic Drugs Market - Forecast to 2018

Information contained on this page is provided by an independent third-party content provider. WorldNow and this Station make no warranties or representations in connection therewith. If you have any questions or comments about this page please contact pressreleases@worldnow.com.

SOURCE Research and Markets

DUBLIN, June 27, 2014 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/9kp9sq/ophthalmic_drugs) has announced the addition of the "2014 Report on the International (Dry eye, Anti-glaucoma, Anti-allergy/inflammatory/infective, Retinal Drugs) Ophthalmic Drugs Market - Forecast to 2018" report to their offering.

http://photos.prnewswire.com/prnh/20130307/600769

The global ophthalmic drugs market is rapidly growing due to increasing prevalence of eye disorders such as glaucoma, dry eye diseases and retinal diseases. Changing lifestyle, improved medical infrastructure, technological changes, increase in healthcare spending and aging population is also supporting the growth of the ophthalmic drugs market.

Glaucoma is the largest drugs segment in global ophthalmic drugs market. Some of the major drugs for glaucoma treatment are Lumigan, Combigan, Xalatan, Ganfort and Saflutan. Diquas, Hyalein and Restasis are the major drugs for dry eye diseases. The retinal drugs market includes Ozurdex, Macugen, Visudyne and Lucentis. Patanol/Pataday, Tobradex, Vigamox and Bepreve are major ocular anti-inflammatory drugs. The ophthalmic drugs market covers prescription based drugs, OTC drugs and pipeline drugs. This report forecasts future potential of all these drug markets and analyses drivers and opportunities, restraints and challenges, market trends, Porter's forces, competitive landscape and company profiles of key players.

The report categorizes the global ophthalmic drugs market based on major eye disorders, treatment drugs and geography. The treatment drugs market comprises treatment of major eye disorders such as glaucoma, dry eye drugs, retinal diseases and ocular inflammatory diseases. The market is further segmented on the basis of prescription based drugs, OTC drugs and pipeline drugs in different eye disorder areas.

In the segment of geographic analysis, the report identifies and analyses market sizes and forecast of North America, Europe, Asia Pacific and Rest of the World (RoW). North America region covers the scenario of the US. Europe region covers the scenario of France, Germany and the UK. Asia Pacific region highlights the scenario of India, China and Japan.

Key Topics Covered:

Chapter 1 Preface

Chapter 2 Executive Summary

Chapter 3 Ophthalmic Drugs - Industry Analysis

Chapter 4 Ophthalmic Drugs Market Trends

Chapter 5 Porter's Five Force Analysis

Chapter 6 Global Market Size and Forecast

Chapter 7 Ophthalmic Drugs Market - Treatment Drugs

Chapter 8 Ophthalmic Drugs Market: Regional Analysis

Chapter 9 Prescription vs. Over the Counter Drugs

Chapter 10 Competitive Landscape

Chapter 11 Company Profiles

Companies Mentioned:

  • Allergan
  • Merck
  • Novartis
  • Pfizer
  • Roche
  • Santen Pharmaceutical

For more information visit http://www.researchandmarkets.com/research/9kp9sq/ophthalmic_drugs

Media Contact: Laura Wood, +353-1-481-1716, press@researchandmarkets.net

©2012 PR Newswire. All Rights Reserved.

Powered by WorldNow